| Application no. and date | 06712292.9 (espacenet) (Federated) (European Patent Register), 20060125 | | Patent/reg. no. and date | DK/EP 1849470, 20170621 | | Publication date | 20071031 | | Priority no. and date | US 42059, 20050126, JP 2005165156, 20050606 | | EP pub. no. and date |
EP 1849470 20071031 | | Effective date | | | Applicant/owner | Taiho Pharmaceutical Co., Ltd., 1-27 Kandanishiki-cho Chiyoda-ku
Tokyo 101-8444, JP | | Applicant ref. no. | P288259DKEP | | Inventor | EMURA, Tomohiro, c/o Taiho Pharmaceutical Co., Ltd.,
1-27, Misugidai
Hanno-shi, Saitama, 357-8527, JP,
MITA, Akira, c/o Taiho Pharmaceutical Co., Ltd.,
1-19, Kandanishiki-cho
Chiyoda-ku, Tokyo, 101-0054, JP | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61K 31/513 (2006.01) , A61K 31/7068 (2006.01) , A61K 31/7072 (2006.01) , A61P 35/00 (2006.01) | | Title | Cancerlægemiddel, som indeholder alpha, alpha, alpha-trifluorthymidin og thymidin-phosphorylase-inhibitor | | Int. application no. | JP2006301097 | | Int. publication no. | WO2006080327 | | Related patent (certificate) | CA 2017 00036 | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
